{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:25:06Z","timestamp":1787685906082,"version":"build-2784847793"},"reference-count":39,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Hum Factors"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Digital health technology enables collection of continuous physiological and behavioral data from participants in clinical trials. This supports hybrid trial designs, potentially reducing clinic visits and participant burden for patient monitoring. Interstitial lung disease (ILD) is characterized by an unpredictable clinical course, creating a need for new treatments and more sensitive approaches to assessing treatment effectiveness, disease progression, and clinically meaningful trial end points.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to explore the experiences of individuals with ILD using digital tools in a clinical study to inform digital health\u2013enabled clinical research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This qualitative study was conducted within the PRODIGY-ILD (Predicting Outcomes using Digital Technology in Interstitial Lung Disease) cohort, a prospective observational study using wearable devices and electronic patient-reported outcome measures for a planned 3 years of longitudinal monitoring. Participants were recruited from a specialist outpatient ILD clinic. A topic guide was developed iteratively, and individual semistructured interviews were conducted remotely via Zoom (Zoom Video Communications, Inc) and\/or telephone, audio-recorded, and transcribed. Data were analyzed using reflexive thematic analysis with NVivo software (Lumivero).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fifteen of the final 20 participants recruited to the PRODIGY-ILD study consented and completed interviews. Four key themes were identified, highlighting how trust, digital literacy, participant-initiated engagement with data, and illness burden shape sustained participation in digital health\u2013enabled clinical research: (1) trust and altruism override data concerns: confidence in researchers\u2019 data handling and a desire to contribute enabled data sharing; (2) navigating digital tools: friction and flexibility: digital literacy, usability, and device compatibility varied, but participants were able to use workarounds to maintain engagement; (3) participant-initiated engagement with wearable data: participants moved from passive to active engagement, in many cases integrating devices into daily routines; and (4) life-limiting illness as a constraint on digital trial participation: managing symptoms and severe comorbidities reduces motivation and engagement with study technology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite participants\u2019 motivations to contribute data to research, engagement was shaped by usability, participant-initiated engagement, and the constraints of living with chronic illness. There is a need for patient-centered design, tailored support, and flexible trial procedures to optimize adherence in digital health\u2013enabled clinical research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/91533","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:13:15Z","timestamp":1787685195000},"page":"e91533-e91533","source":"Crossref","is-referenced-by-count":0,"title":["Patient Experiences of Digital Technology Use in Interstitial Lung Disease (PRODIGY-ILD Study): Qualitative Study Using Reflexive Thematic Analysis"],"prefix":"10.2196","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6939-1586","authenticated-orcid":false,"given":"Emer","family":"Gunne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4241-8718","authenticated-orcid":false,"given":"Alessandro","family":"Franciosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2896-5210","authenticated-orcid":false,"given":"Cormac","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4507-0742","authenticated-orcid":false,"given":"Michael P","family":"Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2064-5335","authenticated-orcid":false,"given":"Peter","family":"Doran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7314-2152","authenticated-orcid":false,"given":"Sinead","family":"Holden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"issue":"9","key":"R1","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"R2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2021-001088","article-title":"Telehealth for patients with interstitial lung diseases (ILD): results of an international survey of clinicians","volume":"8","author":"Althobiani","journal-title":"BMJ Open Respir Res"},{"issue":"4","key":"R3","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00441-2021","article-title":"Home monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and progression: a systematic review","volume":"7","author":"Althobiani","journal-title":"ERJ Open Res"},{"issue":"3","key":"R4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1164\/rccm.202002-0328OC","article-title":"Home monitoring in patients with idiopathic pulmonary fibrosis. A randomized controlled trial","volume":"202","author":"Moor","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"R5","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01518-2020","article-title":"Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial","volume":"58","author":"Noth","journal-title":"Eur Respir J"},{"issue":"7","key":"R6","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1007\/s12325-021-01790-y","article-title":"Disease behaviour during the peri-diagnostic period in patients with suspected interstitial lung disease: the STARLINER study","volume":"38","author":"Wijsenbeek","journal-title":"Adv Ther"},{"issue":"1","key":"R7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000504763","article-title":"Idiopathic pulmonary fibrosis: best practice in monitoring and managing a relentless fibrotic disease","volume":"99","author":"Wuyts","journal-title":"Respiration"},{"issue":"1","key":"R8","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-022-02221-4","article-title":"A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease","volume":"23","author":"Maher","journal-title":"Respir Res"},{"issue":"1","key":"R9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S2213-2600(22)00228-4","article-title":"Home monitoring in interstitial lung diseases","volume":"11","author":"Wijsenbeek","journal-title":"Lancet Respir Med"},{"key":"R10","unstructured":"Apple Heart Study: assessment of wristwatch-based photoplethysmography to identify cardiac arrhythmias. ClinicalTrials.gov. URL: https:\/\/clinicaltrials.gov\/study\/NCT03335800 [Accessed 23-07-2026]"},{"issue":"1","key":"R11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pdig.0000318","article-title":"Supporting self-management for patients with interstitial lung diseases: utility and acceptability of digital devices","volume":"3","author":"Althobiani","journal-title":"PLOS Digit Health"},{"issue":"4","key":"R12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-088271","article-title":"Predicting outcomes using DIGital TechnologY in patients with Interstitial Lung Disease (PRODIGY-ILD): protocol for a prospective cohort study","volume":"15","author":"Gunne","journal-title":"BMJ Open"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","journal-title":"J Biomed Inform"},{"issue":"2","key":"R14","doi-asserted-by":"publisher","DOI":"10.1093\/jamiaopen\/ooac047","article-title":"MyCap: a flexible and configurable platform for mobilizing the participant voice","volume":"5","author":"Harris","journal-title":"JAMIA Open"},{"issue":"6","key":"R15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated Criteria for Reporting Qualitative Research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","journal-title":"Int J Qual Health Care"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.2196\/62761","article-title":"Exploring participants\u2019 experiences of digital health interventions with qualitative methods: guidance for researchers","volume":"26","author":"Harrison Ginsberg","journal-title":"J Med Internet Res"},{"issue":"4","key":"R17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/2159676X.2019.1628806","article-title":"Reflecting on reflexive thematic analysis","volume":"11","author":"Braun","journal-title":"Qual Res Sport Exerc Health"},{"issue":"1","key":"R18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/26895269.2022.2129597","article-title":"Toward good practice in thematic analysis: avoiding common problems and be(com)ing a knowing researcher","volume":"24","author":"Braun","journal-title":"Int J Transgend Health"},{"issue":"3","key":"R19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jclinepi.2013.08.015","article-title":"Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects","volume":"67","author":"McCambridge","journal-title":"J Clin Epidemiol"},{"key":"R20","unstructured":"Digital health technologies for remote data acquisition in clinical investigations. US Food and Drug Administration. URL: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/digital-health-technologies-remote-data-acquisition-clinical-investigations [Accessed 16-01-2026]"},{"issue":"1","key":"R21","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-019-0090-4","article-title":"Developing and adopting safe and effective digital biomarkers to improve patient outcomes","volume":"2","author":"Coravos","journal-title":"NPJ Digit Med"},{"issue":"3","key":"R22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000509725","article-title":"Digital measures that matter to patients: a framework to guide the selection and development of digital measures of health","volume":"4","author":"Manta","journal-title":"Digit Biomark"},{"key":"R23","unstructured":"CTI considerations for advancing the use of digital technologies for data capture & improved clinical trials. Clinical Trials Transformation Initiative; 2021. URL: https:\/\/ctti-clinicaltrials.org\/wp-content\/uploads\/2021\/06\/CTTI_Digital_Health_Technologies_Recs.pdf [Accessed 21-07-2026]"},{"issue":"5","key":"R24","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1093\/rheumatology\/keaa607","article-title":"Feasibility of online home spirometry in systemic sclerosis-associated interstitial lung disease: a pilot study","volume":"60","author":"Moor","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"R25","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00405-2021","article-title":"Worldwide experiences and opinions of healthcare providers on eHealth for patients with interstitial lung diseases in the COVID-19 era","volume":"7","author":"Nakshbandi","journal-title":"ERJ Open Res"},{"issue":"4","key":"R26","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/23294515.2017.1403980","article-title":"Ethical and regulatory challenges of research using pervasive sensing and other emerging technologies: IRB perspectives","volume":"8","author":"Nebeker","journal-title":"AJOB Empir Bioeth"},{"issue":"2","key":"R27","doi-asserted-by":"publisher","DOI":"10.1177\/2053951718819032","article-title":"When digital health meets digital capitalism, how many common goods are at stake?","volume":"5","author":"Sharon","journal-title":"Big Data Soc"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-11-31","article-title":"Reasons for participating in randomised controlled trials: conditional altruism and considerations for self","volume":"11","author":"McCann","journal-title":"Trials"},{"issue":"10","key":"R29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000045.pub2","article-title":"Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis","volume":"10","author":"Houghton","journal-title":"Cochrane Database Syst Rev"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2020.106219","article-title":"Using digital technologies in clinical trials: current and future applications","volume":"100","author":"Rosa","journal-title":"Contemp Clin Trials"},{"issue":"e1","key":"R31","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1093\/jamia\/ocv118","article-title":"Opportunities and challenges in the use of personal health data for health research","volume":"23","author":"Bietz","journal-title":"J Am Med Inform Assoc"},{"issue":"15","key":"R32","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11152140","article-title":"Personalizing digital health: adapting health technology systems to meet the needs of different older populations","volume":"11","author":"Jimenez","journal-title":"Healthcare (Basel)"},{"issue":"3","key":"R33","doi-asserted-by":"publisher","DOI":"10.2196\/18848","article-title":"Digital mental health and COVID-19: using technology today to accelerate the curve on access and quality tomorrow","volume":"7","author":"Torous","journal-title":"JMIR Ment Health"},{"issue":"1","key":"R34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/ehjdh\/ztab005","article-title":"Barriers and facilitators of the uptake of digital health technology in cardiovascular care: a systematic scoping review","volume":"2","author":"Whitelaw","journal-title":"Eur Heart J Digit Health"},{"issue":"8","key":"R35","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/CIN.0000000000000442","article-title":"Facilitators of and barriers to mHealth adoption in older adults with heart failure","volume":"36","author":"Cajita","journal-title":"Comput Inform Nurs"},{"issue":"2","key":"R36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000525080","article-title":"Considerations for conducting bring your own \u201cdevice\u201d (BYOD) clinical studies","volume":"6","author":"Demanuele","journal-title":"Digit Biomark"},{"issue":"1","key":"R37","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-024-01151-3","article-title":"From wearable sensor data to digital biomarker development: ten lessons learned and a framework proposal","volume":"7","author":"Daniore","journal-title":"NPJ Digit Med"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-14-281","article-title":"Rethinking the patient: using Burden of Treatment Theory to understand the changing dynamics of illness","volume":"14","author":"May","journal-title":"BMC Health Serv Res"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.2147\/PROM.S34681","article-title":"Building a measurement framework of burden of treatment in complex patients with chronic conditions: a qualitative study","volume":"3","author":"Eton","journal-title":"Patient Relat Outcome Meas"}],"container-title":["JMIR Human Factors"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:13:17Z","timestamp":1787685197000},"score":1,"resource":{"primary":{"URL":"https:\/\/humanfactors.jmir.org\/2026\/1\/e91533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":39,"URL":"https:\/\/doi.org\/10.2196\/91533","relation":{},"ISSN":["2292-9495"],"issn-type":[{"value":"2292-9495","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"v13i9e91533"}}